Cytokinetics reported $48.22M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 78.11M 11.79M
Acorda Therapeutics ACOR:US USD 23M 7.07M
Amgen AMGN:US USD 1.29B 40M
Arca Biopharma ABIO:US USD 1.74M 513K
Bayer BAYN:GR EUR 4.08B 393M
Biogen BIIB:US USD 563.3M 9.3M
Brainstorm Cell Therapeutics BCLI:US USD 3.06M 587K
Bristol Myers Squibb BMY:US USD 1.93B 147M
Capricor Therapeutics CAPR:US USD 2.56M 208.29K
Cytokinetics CYTK:US USD 48.22M 5.51M
Eisai 4523:JP JPY 88.08B 4.22B
Eli Lilly And LLY:US USD 1.61B 10.9M
Exelixis EXEL:US USD 114.98M 7.78M
Genocea Biosciences GNCA:US USD 3.6M 473K
Geron GERN:US USD 15.64M 8.2M
Halozyme Therapeutics HALO:US USD 34.07M 23.41M
Intra Cellular Therapies ITCI:US USD 88.38M 11.94M
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Merk MRK:US USD 2.47B 13M
Novartis NOVN:VX USD 3.4B 185M
Pfizer PFE:US USD 3.54B 345M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M